Clinical Trial Update: Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating letrozole as early adjuvant therapy for postmenopausal patients with primary breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED